(Rac) -JBJ-04-125-02

JBJ-04-125-02 is effective as a single agent in both in vitro and in vivo models of EGFR-mutant lung cancer.

2140807-05-0

≥ 2 years

>98% (HPLC)

543.6

C29H26FN5O3S

Research use only, not for human use.

EGFR (L858R/T790M)

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

46225026 500 ng

Ask

TL309752 1 Kit

Ask

NB110-92756FR 0.1 mL

Ask

ABC-KH6134 1 Vial

Ask

E55P1125 50 µg

Ask